How a malaria drug may hold the key to ending malnutrition’s cycle of devastation

Wars, drought, displacement, and instability are causing a dramatic increase in the number of pregnant and breastfeeding women around the world who suffer from malnutrition.

Kyowa Kirin acquires Orchard Therapeutics for $477.6m

Share this article The deal will enhance Kyowa Kirin’s focus on addressing the unmet medical needs of individuals with genetic and other severe diseases. Credit:

January 25, 2024

In pivot to buzzy ADCs, London biotech Myricx raises $114M with Lilly’s support

On the verge of raising its Series A in late 2021, Myricx Bio faced a tough choice. The toxicity profile for its IV and oral

July 8, 2024

Immunic to Participate in Investor and Scientific Conferences in May – Biotech Investments

Issuer: Immunic AG / Key word(s): Conference 06.05.2024 / 12:30 CET/CEST The issuer is solely responsible for the content of this announcement. Immunic to Participate

May 7, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.